Global Home Global Home  



Press Releases

= Add Release to Briefcase



Mar 9, 2018 Sonoma Pharmaceuticals to Present at Roth Capital Partners 30th Annual Growth Stock Conference on March 13, 2018 PDF 18.7 KB Add to Briefcase
Mar 6, 2018 Sonoma Pharmaceuticals Announces Closing of $5 Million Public Offering of Common Stock PDF 20.0 KB Add to Briefcase
Mar 2, 2018 Sonoma Pharmaceuticals Announces Pricing of $5 Million Public Offering of Common Stock PDF 19.2 KB Add to Briefcase
Feb 7, 2018 Sonoma Pharmaceuticals Reports Record Total Revenue of $4.8 million for Third Quarter FY 2018 with Year over Year Product Revenue Growth of 46% PDF 51.5 KB Add to Briefcase
Jan 25, 2018 Sonoma Pharmaceuticals Announces Fiscal Third Quarter 2018 Financial Results and Conference Call PDF 17.2 KB Add to Briefcase
Jan 9, 2018 Sonoma Pharmaceuticals Receives Three New United Arab Emirates Regulatory Approvals: Acuicyn® for Management of Blepharitis, Microsafe® Oral Care for Mucositis and Sinudox® for Chronic Sinusitis PDF 21.7 KB Add to Briefcase
Dec 5, 2017 Sonoma Pharmaceuticals Announces Second FDA Approval to Add Antimicrobial Language to Alevicyn™ Gel Products for Management of Atopic Dermatitis PDF 19.8 KB Add to Briefcase
Nov 16, 2017 Sonoma Pharmaceuticals Announces FDA Approval of Expanded Indication for Alevicyn™ to Add Antimicrobial Language PDF 17.9 KB Add to Briefcase
Nov 9, 2017 Sonoma Pharmaceuticals Reports Robust Top Line Growth for Second Quarter FY 2018 with 61% Product Revenue Growth and Total Revenue of $4.3 Million PDF 48.0 KB Add to Briefcase
Oct 31, 2017 Sonoma Pharmaceuticals Receives Brazilian Approvals to Market Multiple Hypochlorous Acid-Based Dermatology Products PDF 20.4 KB Add to Briefcase

Showing 1-10 of 76

Page: 1 2 3 ... 8

 Next 10